Sex Differences in Long-Term Cardiovascular Outcomes and Mortality After COVID-19 Hospitalization During Alpha, Delta and Omicron Waves
Authors:
- Kristen KoppKristen Kopp
- Lukas J. MotlochLMLukas J. Motloch
- Michael LichtenauerMichael Lichtenauer
- Elke BoxhammerEBElke Boxhammer
- Uta C. HoppeUHUta C. Hoppe
- Alexander E. BerezinAlexander E. Berezin
- Diana GareevaDGDiana Gareeva
- Irina LakmanILIrina Lakman
- Alexander AgapitovAAAlexander Agapitov
- Liana SadikovaLSLiana Sadikova
- Venera TimiryanovaVenera Timiryanova
- Paruir DavtyanPDParuir Davtyan
Open Access
- 5 November 2024
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (22) , 6636
Abstract
Background: Increased mortality and occurrence of cardiovascular (CV) outcomes during hospitalization and in short-term follow-up for moderate to severe SARS-CoV-2 infection have been associated with male sex, yet data regarding long-term outcomes by sex and COVID-19 variant (Alpha, Delta, and Omicron) are limited. Methods: This prospective study of 4882 patients examines potential differences by sex in the occurrence of primary combined cardiovascular outcomes (CV death, CV hospitalization, myocardial infarction (MI), stroke, pulmonary embolism) as well as secondary outcomes (CV death, cardiovascular hospitalizations, myocardial infarction, stroke, pulmonary embolism) at 18-month follow-up after urgent hospitalization for SARS-CoV-2-associated pneumonia, as well as evaluating for differences during the three COVID-19 waves. Survival rate was analyzed for the entire cohort by sex and SARS-CoV-2 variant and adjusted for age using the multiple Kaplan–Meier method. To compare survival in groups of men and women for each wave, the Gehan–Wilcoxon test was applied with significance p < 0.05. Univariate Cox proportional hazards models were used to search for potential risk factors of CV death at 18-months follow-up separately for men and women in each COVID-19 wave. Results: Men had significantly higher 18-month CV mortality compared to women in the Delta wave (6.13% men vs. 3.62% women, p = 0.017). Although men had higher percentages of all other CV endpoints (excepting pulmonary embolism) at follow-up during the Delta wave, none were significant compared with women, except for the combined CV endpoint (16.87% men vs. 12.61% women, p = 0.017). No significant differences by sex in CV outcomes were seen during the Alpha and Omicron variants. Discrepancies in CV outcomes in demographical data and concomitant disease between the COVID-19 variants of concern existed. Conclusions: Higher male mortality and higher but non-significant incidences of CV outcomes occurred during the Delta wave of the COVID-19 pandemic, with the lowest incidence of CV outcomes observed during the Omicron variant.Keywords
Funding Information
- Russian Science Foundation (22-18-20123)
This publication has 51 references indexed in Scilit:
- COVID-19−Associated Acute Kidney Injury and Longitudinal Kidney OutcomesJAMA Internal Medicine, 2024
- Different patterns of excess all-cause mortality by age and sex in Hungary during the 2nd and 3rd waves of the COVID-19 pandemicGeroScience, 2022
- Sequelae of COVID-19 among previously hospitalized patients up to 1 year after discharge: a systematic review and meta-analysisInfection, 2022
- Sex differences in the mortality rate for coronavirus disease 2019 compared to other causes of death: an analysis of population-wide data from 63 countriesEuropean Journal of Epidemiology, 2022
- Sex-disaggregated data matters: tracking the impact of COVID-19 on the health of women and menEconomia Politica, 2022
- Risk and Protective Factors for COVID-19 Morbidity, Severity, and MortalityClinical Reviews in Allergy & Immunology, 2022
- Acute and post-acute neurological manifestations of COVID-19: present findings, critical appraisal, and future directionsJournal of Neurology, 2021
- Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 InfectionJAMA Network Open, 2021
- Sex hormones, autoimmunity and gender disparity in COVID-19Rheumatology International, 2021
- The effect of smoking on COVID‐19 severity: A systematic review and meta‐analysisJournal of Medical Virology, 2020